Landscapes / Targets
IL-15Ra
3 drugs act on IL-15Ra, in 20 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
IL-15 receptor agonist |
Approved | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Bladder Cancer, Urothelial Carcinoma and 31 more | ||||
| Open drug page | |||||
— |
3SBio · Public 1530.HK |
Phase 2 | Nov 2027Phase 2 trial completes | ||
| Next date | Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Malignant Tumors, NMIBC and 1 more | ||||
| Open drug page | |||||
— |
Roche · Public ROG.SW |
Phase 1 | 18 Nov 2026soonPhase 1 trial completes | ||
| Next date | 18 Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026